The U.S. Food and Drug Administration (FDA) issued a constituent update to the dietary supplement industry that signals the agency's intent to amend the labeling regulation that currently calls for ...
UPLIZNA Offers gMG Patients Deep and Durable Symptom Control and Twice-Yearly Dosing* First and Only CD19-Targeted B Cell Therapy Approved in anti-AChR and anti-MuSK ...
While the FDA is streamlining regulation of copycat versions of the expensive drugs that millions take for arthritis, cancer and other diseases, the U.S. patent office is making it harder for the ...
In the food and beverage industry, both utility and design patents can be vital to intellectual property protection. They allow companies to mark their products as ...
NEW YORK – The US Food and Drug Administration on Tuesday released a proposal to reclassify companion diagnostic assays from Class III medical devices to Class II devices. In its proposal in the ...
The U.S. Coast Guard has released a new, firmer policy addressing the display of hate symbols like swastikas and nooses just hours after it was publicly revealed that it made plans to describe them as ...
Ajanta Pharma and its U.S. affiliate were hit with a patent infringement lawsuit on Nov. 20 in New Jersey District Court. The action, brought by Morgan Lewis & Bockius on behalf of Salix ...
Tarlatamab-dlle received FDA approval for ES-SCLC after showing a 40% reduction in death risk compared with chemotherapy in the DeLLphi-304 trial. The trial demonstrated improved overall survival ...
Patent adds to Envoy Medical’s expanding intellectual property portfolio, reinforcing the Company’s leadership in next generation cochlear implant innovation White Bear Lake, Minnesota--(Newsfile Corp ...
In our latest IPWatchdog Unleashed podcast, I spoke with Rob Sahr, shareholder at Wolf Greenfield and co-chair of our 2025 Life Sciences Masters™ program. Our conversation zeroed in on a hard truth ...
ERIC urges the USPTO to withdraw the rule and collaborate on a patent process that promotes competition, lowers costs and improves access to medicines. Gelfand added, "We urge the USPTO to withdraw ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback